- DIRECTOR Institute for Crititcal Care Medicine
- SENIOR FACULTY Neurology
- SENIOR FACULTY Neurosurgery
MD, Cornell University Medical College
Internship, Internal Medicine
New York Presbyterian Hospital
New York Presbyterian Hospital
Fellowship, Neurocritical Care
Columbia- Presbyterian Medical Center
Stephan A. Mayer, MD, FCCM, is founding Director of the Institute for Critical Care Medicine at the Icahn School of Medicine at Mount Sinai. In this new role he is responsible for overseeing the clinical, educational and research operations of the adult critical care environment throughout the Mount Sinai Health System, which now spans across six hospitals across New York City. Prior to that Dr. Mayer was Director of Neurocritical Care and Professor of Neurology and Neurological Surgery at Columbia University College of Physicians and Surgeons in New York, NY.
Dr Mayer earned his medical degree from Cornell University Medical College in New York City. He completed a residency in neurology and a fellowship in critical care neurology at the Neurological Institute of New York, Columbia-Presbyterian Medical Center. He is board certified in psychiatry and neurology and is certified as a diplomate in neurocritical care by the United Council of Neurologic Subspecialties.
Dr Mayer is a fellow of the American College of Critical Care Medicine and the Stroke Council of the American Heart Association. He was a founding member and has served as past-president of the Neurocritical Care Society. Dr. Mayer has published more than500 journal articles, books, case reports, book chapters, and abstracts. He was principal investigator of the FAST Trial, a worldwide multicenter clinical trial evaluating ultra-early hemostatic therapy for brain hemorrhage, and served as principal investigator of the NIH-funded New York Presbyterian Hospital hub of the Neurological Emergencies Treatment Trials (NETT) network. His work in helping to organize therapeutic hypothermia for victims of cardiac arrest in New York City was recently featured in the book Cheating Death, by CNN medical correspondant Dr. Sanjay Gupta.
For a complete list of Dr. Mayer's publications click here.
American Heart Association, NYC Chapter
Lifetime Achievement Award
International Pan Arab Critical Care Medicine Society
American College of Critical Care Medicine
Castle & Connelly
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Mayer during 2014 and/or 2015. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Biogen Idec; C. R. Bard, Inc.; CSL Behring; Codman & Shurtleff, Inc. (DePuy, Inc.); Cornerstone Therapeutics; General Electric Company; Orsan Medical Technologies; Pfizer Inc.; SAGE Therapeutics
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Health System (MSHS) physicians - including those employed by MSHS - do not always participate in the same health plans in which MSHS hospitals or facilities participate.
Information regarding insurance participation and billing by this physician may be found on this page or obtained by contacting this provider directly.
Insurance plans that the Mount Sinai Health System hospitals or facilities participate in can be found on the Mount Sinai Health System website.
Klingenstein Clinical Center First Floor North
1450 Madison Avenue
New York, NY 10029